ما هو علاج اعتلال عضلة القلب البطيني الأيمن المولِّد لاضطرابات النظم؟

References

• Beta-blockers constitute the first option to reduce arrhythmic burden via a reduction in adrenergic tone, particularly on exercise.
• Titration to the maximal tolerated dose has been associated with an improvement in survival from major ventricular arrhythmias in retrospective observational studies.
• Beta-blocker therapy is recommended in ARVC patients with VE, NSVT, and VT.
• Discontinuation of intense physical exercise has shown a potential to slow the pace of disease progression and reduce the ventricular arrhythmia burden.